Biblio
Filters: Author is SINGH [Clear All Filters]
Yadav, V P, Pandeya SN, Kumar V, Singh UK, Kukshal A.
2008. Synthesis & antimicrobial activity of 7-chloro-6-fluoro-N- [(1E)-(4-substituted phenyl) methylidene]-1,3-benzathiazole-2-amine. INDIAN DRUGS. 45(8)(August):655-658. Abstract
VR, S, A S, S S, JR. B.
2007. Compression coated systems for colonic delivery of 5-fluorouracil.. J Pharm Pharmacol.
VR, S, A S, S S, JR. B.
2007. Compression coated systems for colonic delivery of 5-fluorouracil.. J Pharm Pharmacol.
visagaperumal, D, Venkatesan P, Thiruganesh R, Sugumaran M, Bansal GK, Singh M, Ravichandiran V.
2004. Novel synthesis of chloromethyl biphenyl carboxylic acid. indian pharmacist. :67-70.
Varun Singh Bhati M. M. Gupta, S Y G SKN.
Submitted. Dossier Submission to TGA for prescription only medicines. Indian Journal of Pharmaceutical Education and Research (IJPER) India..
and V. R. Sinha M. K. Agrawal, A SAG, Ghai D.
Submitted. Extrusion-spheronization: Process variables and characterization. Critical Reviews™ in Therapeutic Drug Carrier Systems.
Sugumaran, M, Vetrichelvan T, Singh M.
2006. Renin –Angiotensin system- A target for anti hypertensive drug. The antiseptic. 103(3):153-154.
Sugumaran, M, Vetrichelvan T, DarlinQuine S, Singh. D.
2007. Pharmacognostical and pharmacological studies of Pithecellobium dulce Benth leaf,. Pharma buzz. 2(12):48-52.
Sinha V. R., GD, G. S.
2008. Formulation and characterization of microemulsion based topical systems for Ketoprofen.. IPC December 2008..
Singh, A P, Girdharwal N.
2007. A Study of Physicians Behaviour toward Marketing of Pharmaceutical Products (A Case Study of Indian Market). Abstract
Singh, G P.
2008. A Study On awareness Regarding Consumer Legislation And Media Information Sources In India. Swani Shukdevanand International Seminar on Consumer Legislation in India . Abstract
dharmender singh.
2009. Development and Characterization of chitosan nanoparticles loaded with Amoxicillin. PHARMACY. :10. Abstract
dharmendra singh.
2009. NASAL DRUG DELIVERY SYSTEM: DESIGNING OF NASAL PRODUCT-POSSIBILITY & PROBLEM . NASAL DRUG DELIVERY SYSTEM: DESIGNING OF NASAL PRODUCT-POSSIBILITY & PROBLEM . :9. Abstract
dharmendra singh.
2009. NASAL DRUG DELIVERY SYSTEM: DESIGNING OF NASAL PRODUCT-POSSIBILITY & PROBLEM . NASAL DRUG DELIVERY SYSTEM: DESIGNING OF NASAL PRODUCT-POSSIBILITY & PROBLEM . :9.
Singh, SN, Mishra DN, Singh SK, Kumar U, Pathak D, Pathak K.
1998. Enzyme Inhibitors as target for Drug Design. The Eastern Pharmacist. The Eastern Pharmacist.
Sharma, S, Sharma K, Geete A, Parihar A S, Khan M. Y, Kumar V.
2008. RADIOPROTECTION THROUGH HERBS. Abstract
Satish Singh Kadian*, Harikumar SL.
2009. Eudragit and its Pharmaceutical Significance. Eudragit and its Pharmaceutical Significance. :17.
Sastry, KSM, Singh P, Rao SMVV, Subrahmanyam CVS.
1988. Possibility of Utilising Industrial Residues for Gibberellic Acid Fermentation. Ind. J. Expt. Biol.. 26:4.

]